DSG Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
DSG Capital Advisors's LLY Position: Q3 2026 in Review
DSG Capital Advisors reduced its Eli Lilly (LLY) stake by 3% in Q3 2026, selling an estimated $1.2M and leaving 32,491 shares worth $37.6M. The position accounts for 5.37% of the portfolio, ranked #3.
DSG Capital Advisors first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $38.6M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- DSG Capital Advisors held 32,491 shares of Eli Lilly worth $37.6M as of Q3 2026.
- DSG Capital Advisors sold 1,016 Eli Lilly shares in Q3 2026, an estimated $1.2M.
- Eli Lilly made up 5.37% of DSG Capital Advisors's portfolio in Q3 2026, its #3 holding.
- DSG Capital Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- DSG Capital Advisors's Eli Lilly position peaked at $38.6M in Q2 2026.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on DSG Capital Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.